Vol.

No.

August 06, 2021Aug 06, 2021

Free

DOWNLOAD THE PDF

Cancer Crusade tells the gripping story of the National Cancer Act

Cover Story

Cancer History Project Free

Cancer Crusade tells the gripping story of the National Cancer Act

By Otis W. Brawley and Paul Goldberg

First published in 1977, Cancer Crusade: The Story of the National Cancer Act of 1971, is a dispassionate legislative history—a book you can trust.

Editorial Free

Summer reading issue 2021: Reflecting on two years of reckoning

By Matthew Bin Han Ong

Book Review Free

What are you reading in 2021?

Book Review Free

Books that mattered to me this year

By Wafik S. El-Deiry

Cancer History Project Free

The history—and future—of oncology, according to directors of the first three NCI-designated Comprehensive Cancer Centers
“There couldn’t be a better time to be in oncology”

By Katie Goldberg and Alexandria Carolan

Free In the Archives

Midway through the 50th anniversary year of the National Cancer Act, what have we learned?

In Brief

OIG to review FDA’s accelerated approval pathway

Jim Gabriele named president and CEO of M2GEN

Memorial Sloan Kettering establishes MSKCC India

New software to capture worldwide cancer data

Clinical Roundup

Keytruda significantly prolonged RFS compared to placebo as adjuvant therapy in phase III KEYNOTE-716 Trial

International collaboration helps refine treatment for childhood leukemia

Comprehensive clinical sequencing opens door to the promise of precision medicine

Statins may improve survival for triple-negative breast cancer patients

Drugs & Targets

Opdivo receives EC approval in Esophageal/GEJ indication

FDA grants Priority Review to Tecentriq as adjuvant treatment in NSCLC indication

Cabometyx sNDA receives FDA priority review for previously treated radioactive iodine-refractory differentiated thyroid cancer

BMS issues statement on Istodax relapsed/refractory peripheral T-cell lymphoma U.S. indication

NCI Trials

NCI Trials for August 2021

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE